These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

935 related items for PubMed ID: 15853597

  • 1. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O.
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [Abstract] [Full Text] [Related]

  • 2. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E, DeFronzo RA.
    Diabetes Metab Res Rev; 2006 Mar; 22(6):423-36. PubMed ID: 16506274
    [Abstract] [Full Text] [Related]

  • 3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM, Olijhoek JK, Visseren FL.
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH, Schernthaner G.
    Scand J Clin Lab Invest Suppl; 2005 Jan; 240():30-40. PubMed ID: 16112958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cardiovascular manifestations of insulin resistance.
    Chahwala V, Arora R.
    Am J Ther; 2009 Jan; 16(5):e14-28. PubMed ID: 19114874
    [Abstract] [Full Text] [Related]

  • 10. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE.
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [Abstract] [Full Text] [Related]

  • 11. [Adipocytokins, obesity and development of type 2 diabetes].
    Lacquemant C, Vasseur F, Leprêtre F, Froguel P.
    Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
    [Abstract] [Full Text] [Related]

  • 12. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ.
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D, Nyström T.
    Mol Cell Endocrinol; 2009 Jan 15; 297(1-2):112-26. PubMed ID: 19038307
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The endothelial dysfunction in diabetes mellitus.
    Pănuş C, Moţa M, Vladu D, Vanghelie L, Răducanu CL.
    Rom J Intern Med; 2003 Jan 15; 41(1):27-33. PubMed ID: 15529582
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.